𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor thromboplastin activity In vitro

✍ Scribed by E. Douglas Holyoke; Arthur L. Frank; Leonard Weiss


Publisher
John Wiley and Sons
Year
1972
Tongue
French
Weight
651 KB
Volume
9
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The thromboplastin activity of tissue culture media, before and after incubation with T‐241 Lewis sarcoma cells of mouse origin, or with embryonic mouse epithelial or muscle fibroblasts, was measured by means of a calcium reconstitution assay. Incubation of the embryonic epithelial or muscle fibroblasts increased the thromboplastin activity of the tissue culture media more than did incubation with tumor cells, even though analysis of protein showed that there were more tumor cells than normal cells present at the time of incubation. It is concluded that there is no evidence for a unique β€œCancer Coagulative Factor” at least in this system. In vitro studies of the effect of trauma in increasing the release of thromboplastin activity from both normal and tumor tissues, suggest that the mutual destruction of both tissues could account for the elevated levels observed in some patients with cancer.


πŸ“œ SIMILAR VOLUMES


Tumor fluid thromboplastin activity
✍ Arthur L. Frank; E. DouglasHolyoke πŸ“‚ Article πŸ“… 1968 πŸ› John Wiley and Sons 🌐 French βš– 363 KB

The thromboplastin activity of T-241 Lewis sarcoma peripheral fluid and control subcutaneous Jiltid in C57BL/6Ja male mice was measured, using a calcium reconstitiition assay. The material was collected in Millipore filter chambers. At low dilutions of the collected material there was a statistical

CEP-751 inhibits trk receptor tyrosine k
✍ Anna Marie Camoratto; Jitesh P. Jani; Thelma S. Angeles; Anna C. Maroney; Christ πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 134 KB πŸ‘ 1 views

The present report describes the in vitro and in vivo profile of CEP-751, a novel receptor tyrosine kinase inhibitor. CEP-751 at 100 nM inhibits the receptor tyrosine kinase activity of the neurotrophin receptors trkA, trkB and trkC. CEP-751 has no effect on activity of receptors for EGF, IGF-I, ins